HighTower Advisors’s Biodesix BDSX Stock Holding History

HighTower Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$228K	Buy	+7,646	New	+$189K	﹤0.01%	3444
2025 Q3	–	Sell	-7,963	Closed	-$44.9K	–	3840
2025 Q2	$44.9K	Buy	7,963 +166	+2%	+$1.34K	﹤0.01%	3556
2025 Q1	$97.5K	Buy	7,797 +100	+1%	+$1.92K	﹤0.01%	3364
2024 Q4	$236K	Buy	7,697 +1,125	+17%	+$33.1K	﹤0.01%	3075
2024 Q3	$234K	Hold	6,572	–	–	﹤0.01%	3012
2024 Q2	$202K	Hold	6,572	–	–	﹤0.01%	3017
2024 Q1	$188K	Hold	6,572	–	–	﹤0.01%	3004
2023 Q4	$242K	Sell	6,572 -250	-4%	-$7.85K	﹤0.01%	2875
2023 Q3	$225K	Hold	6,822	–	–	﹤0.01%	2821
2023 Q2	$167K	Hold	6,822	–	–	﹤0.01%	2933
2023 Q1	$254K	Hold	6,822	–	–	﹤0.01%	2572
2022 Q4	$314K	Buy	+6,822	New	+$185K	﹤0.01%	2432

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Thompson Davis & Co Richmond, Virginia $149M AUM 10.53% 1-Year Est. Return

NIA Impact Advisors Berkeley, California $232M AUM 31.81% 1-Year Est. Return

HighTower Advisors's BDSX Position: Q3 2026 in Review

HighTower Advisors opened a new position in Biodesix (BDSX) in Q3 2026: 7,646 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #3444 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in BDSX as recently as Q2 2025.

HighTower Advisors first reported a position in BDSX in Q4 2022 and has held it in 12 quarters since. The position peaked at $314K in Q4 2022. 18 funds tracked by Wall St. Rank hold BDSX as of Q3 2026.

HighTower Advisors held 7,646 shares of Biodesix worth $228K as of Q3 2026.
Biodesix was a new HighTower Advisors position in Q3 2026.
Biodesix made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3444 holding.
HighTower Advisors first reported a position in Biodesix in Q4 2022 and has held it in 12 quarters since.
HighTower Advisors's Biodesix position peaked at $314K in Q4 2022.
18 funds tracked by Wall St. Rank held Biodesix as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.